Coronavirus HIGHLIGHTS: Maharashtra Records 14,152 New Covid Cases, 289 Deaths In Last 24 Hrs
Coronavirus HIGHLIGHTS, Friday, June 4, 2021: While the Modi government is working to ramp up vaccine production in the country to battle the shortage, the Biden administration said that increase in the manufacturing capacity of COVID-19 vaccines in India has the potential to be a game-changer well beyond its borders. America's top infectious disease specialist Dr. Anthony Fauci also said that his country is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID-19 therapeutics.
LIVE
Background
Coronavirus HIGHLIGHTS, Friday, June 4, 2021: Increase in manufacturing capacity of COVID-19 vaccines in India has the potential to be a game changer well beyond its borders, the Biden Administration said Thursday.
"It's important to us because India has suffered immensely from the outbreak. Virtually, no element of Indian society has been left untouched by this horrible scourge. That is why we have spoken of the focus on increased manufacturing in India," State Department spokesperson Ned Price told reporters.
"The increased manufacturing capacity in India, the volume of capacity has the potential to be a game changer well beyond India's borders. And that's precisely why this arrangement was reached and announced in the context of the Quad," he said.
America's top infectious disease specialist Dr Anthony Fauci on Thursday said his country is eager to involve Indian investigators in global clinical trials to evaluate the safety and efficacy of COVID-19 therapeutics.
The National Institute of Allergy and Infectious Diseases has a long history of collaboration with its counterpart agencies in India, Dr Fauci said during a conversation organised by the US-India Strategic and Partnership Forum.
Under the long-standing Indo-US vaccine action programme, we will continue to work with India on research related to SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) vaccines. We also are eager to involve Indian investigators in sites in global clinical trials to evaluate the safety and efficacy of various COVID-19 therapeutics, he said.
J&K Records 1,723 Fresh Covid Cases In 24 Hrs
Jammu and Kashmir on Friday recorded 1,723 fresh COVID-19 cases, raising its tally to 2,97,602, while 34 more deaths pushed the fatality count 4,026 in the union territory, officials said. Of the fresh cases, 599 were from the Jammu division and 1,124 from the Kashmir division.
Bihar Reports Less Than 1,000 COVID Cases After 2 Months
In a strong indication of the let-up in COVID-19 second wave across Bihar, the state on Friday reported less than 1,000 fresh cases, slightly over a score of fatalities, and was left with an active caseload a little above 10,000.
According to the health department, the number of fresh cases was 991, the lowest daily rise in the tally for the last couple of months during which close to five lakh people caught the contagion in the state.
Maharashtra Records 14,152 New Covid Cases, 289 Deaths In Last 24 Hrs
Vaccines: BMC Cancels 9 Global Tenders, But Will Get Sputnik Soon
The BrihanMumbai Municipal Corporation (BMC) has cancelled all 9 global bids it received for supply of Covid-19 vaccines, but Mumbaikars may soon get the Sputnik V jabs, top officials said here on Friday.
Mumbai Mayor Kishori Pednekar said that in early May, in view of the shortages of the life-saving doses, the BMC had floated global tenders for supply of around one crore vaccines which would be administered free to Mumbaikars, and the tender deadlines were extended twice.
Delta Variant Prominently Found In Covid-19 Cases In UP's Varanasi
Banaras Hindu University (BHU), Varanasi, and CSIR-Centre for Cellular and Molecular Biology (CCMB), have collaboratively sequenced genomes of coronavirus variants in the temple town and adjoining areas.
Their study reports at least seven major strains of coronavirus circulating in these regions, a press release from the CCMB said on Friday.
Top Headlines
Trending News
